Business
Anteris (ASX:AVR) share price drops 7% despite positive announcement
The Anteris Technologies Ltd (ASX: AVR) share price is plunging today despite the company declaring “outstanding” results from one of its medical products.
At the time of writing, shares in the medical technology company are trading at $11.9, down 7.67%. By comparison S&P/ASX All Ordinaries Index (ASX: XAO) is down 0.14%.
Anteris, formerly known as Admedus Ltd, focuses on designing and manufacturing heart valves. Its next-generation technology re-engineers xenograft tissue into pure collagen scaffold, helping surgeons replace valves for patients during surgery.
What did Anteris announce today?
The Anteris share price is not…
-
Noosa News15 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
Noosa News18 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
General14 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
General16 hours agoCanberra man named as doctor accused of rape after suppression order lifted